News Focus
News Focus
Followers 206
Posts 13678
Boards Moderated 1
Alias Born 02/04/2001

Re: SSDBase post# 12880

Thursday, 12/06/2012 7:03:50 PM

Thursday, December 06, 2012 7:03:50 PM

Post# of 405172

5. Why are they putting out interim updates on Phase I studies? Phase I is just safety. Positive Phase I results aren't that big of a deal. It will be good if the drug doesn't kill anyone, but the sample size is far to small to produce any kind of statistically significant results on efficacy. So what is the point of putting out PRs for small steps in a study Phase that isn't even that big a deal when it is done?



You are a hot dog so I wont bother teaching you where to find the protocol. I can tell you havent read and understood it by your remarks. You must also be blind to the power of P53 activation
because you fail to understand that IS THE BALLGAME. We WILL KNOW from the testing that CAN NOW BE DONE that p53 IS ACTIVATED and that KEVETRIN will be effective in 50% of all cancers. There is a high probability that the FDA gives them BREAKTHROUGH DRUG status and a PDUFA date at the end of PHASE I.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y